Trial Profile
A Study to Evaluate Whether Induction With Antithymocyte Globulin is Associated With Decreased Coronary Plaque Progression in Patients Who Underwent Cardiac Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Heart transplant rejection
- Focus Pharmacodynamics; Therapeutic Use
- 18 May 2016 New trial record